TriangleFOR PATIENTS · SOURCE READING
Treatment of Limited-Stage Small Cell Lung Cancer
Source: Small Cell Lung Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 8, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Treatment of limited-stage small cell lung cancer may include:
Source links and citations
combination chemotherapy and radiation therapy to the chest
Source links and citations
immunotherapy (durvalumab) after chemoradiation therapy
Source links and citations
combination chemotherapy alone, for patients who cannot receive radiation therapy
surgery followed by chemotherapy
Source links and citations
surgery followed by chemoradiation therapy
radiation therapy to the brain, for patients who have had a complete response to chemotherapy, to prevent the spread of cancer to the brain
Source links and citations
Learn more about these treatments in the Treatment Option Overview.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice